Welcome to
On Feet Nation
This report studies the Biologics and Biosimilars market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by Sales Channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Biologics and Biosimilars from 2015-2020, and provides extensive market forecasts from 2021-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Biologics and Biosimilars market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
ALSO READ : http://www.marketwatch.com/story/biologics-and-biosimilars-market-r...
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Biologics and Biosimilars including:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-robotic...
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Market split by Type, can be divided into:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market split by Application, can be divided into:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-video-c...
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
ALSO READ : http://www.marketwatch.com/story/june-2021-report-on-global-employe...
Table of Contents
Chapter 1 Biologics and Biosimilars Market Overview
1.1 Biologics and Biosimilars Definition
1.2 Global Biologics and Biosimilars Market Size Status and Outlook (2015-2030)
1.3 Global Biologics and Biosimilars Market Size Comparison by Region (2015-2030)
1.4 Global Biologics and Biosimilars Market Size Comparison by Type (2015-2030)
1.5 Global Biologics and Biosimilars Market Size Comparison by Application (2015-2030)
1.6 Global Biologics and Biosimilars Market Size Comparison by Sales Channel (2015-2030)
1.7 Biologics and Biosimilars Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Biologics and Biosimilars Market Segment Analysis by Player
2.1 Global Biologics and Biosimilars Sales and Market Share by Player (2018-2020)
2.2 Global Biologics and Biosimilars Revenue and Market Share by Player (2018-2020)
2.3 Global Biologics and Biosimilars Average Price by Player (2018-2020)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biologics and Biosimilars Market Segment Analysis by Type
3.1 Global Biologics and Biosimilars Market by Type
3.1.1 Monoclonal Antibodies
3.1.2 Interferon
3.1.3 Erythropoietin
3.1.4 Insulin
3.1.5 Vaccines
3.2 Global Biologics and Biosimilars Sales and Market Share by Type (2015-2020)
3.3 Global Biologics and Biosimilars Revenue and Market Share by Type (2015-2020)
3.4 Global Biologics and Biosimilars Average Price by Type (2015-2020)
3.5 Leading Players of Biologics and Biosimilars by Type in 2020
3.6 Conclusion of Segment by Type
Chapter 4 Biologics and Biosimilars Market Segment Analysis by Application
4.1 Global Biologics and Biosimilars Market by Application
4.1.1 Tumor
4.1.2 Diabetes
4.1.3 Cardiovascular
4.1.4 Hemophilia
4.1.5 Other
4.2 Global Biologics and Biosimilars Revenue and Market Share by Application (2015-2020)
4.3 Leading Consumers of Biologics and Biosimilars by Application in 2020
4.4 Conclusion of Segment by Application
Chapter 5 Biologics and Biosimilars Market Segment Analysis by Sales Channel
5.1 Global Biologics and Biosimilars Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Biologics and Biosimilars Revenue and Market Share by Sales Channel (2015-2020)
5.3 Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2020
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biologics and Biosimilars Market Segment Analysis by Region
6.1 Global Biologics and Biosimilars Market Size and CAGR by Region (2015-2030)
6.2 Global Biologics and Biosimilars Sales and Market Share by Region (2015-2020)
6.3 Global Biologics and Biosimilars Revenue and Market Share by Region (2015-2020)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biologics and Biosimilars Market Share by Type
6.4.3 North America Biologics and Biosimilars Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biologics and Biosimilars Market Share by Type
6.5.3 Europe Biologics and Biosimilars Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biologics and Biosimilars Market Share by Type
6.6.3 Asia-Pacific Biologics and Biosimilars Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biologics and Biosimilars Market Share by Type
6.7.3 South America Biologics and Biosimilars Market Share by Application
ALSO READ : http://www.marketwatch.com/story/mobile-app-analytics-software-mark...
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biologics and Biosimilars Market Share by Type
6.8.3 Middle East & Africa Biologics and Biosimilars Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biologics and Biosimilars Players
7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Roche
7.2 Amgen
7.3 AbbVie
7.4 Sanofi-Aventis
7.5 Johnson & Johnson
7.6 Pfizer
7.7 Novo Nordisk
7.8 Eli Lilly
7.9 Novartis
7.10 Merck
7.11 3sbio
7.12 Changchun High Tech
7.13 CP Guojian
7.14 Biotech
7.15 Gelgen
7.16 Innovent
7.17 Dong Bao
7.18 Ganlee
Chapter 8 Upstream and Downstream Analysis of Biologics and Biosimilars
8.1 Industrial Chain of Biologics and Biosimilars
8.2 Upstream of Biologics and Biosimilars
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Biologics and Biosimilars
8.3.1 Leading Distributors/Dealers of Biologics and Biosimilars
8.3.2 Leading Consumers of Biologics and Biosimilars
Chapter 9 Development Trend of Biologics and Biosimilars (2021-2030)
9.1 Global Biologics and Biosimilars Market Size (Sales and Revenue) Forecast (2021-2030)
9.2 Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2021-2030)
9.3 Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2021-2030)
9.4 Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2021-2030)
9.5 Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2021-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Biologics and Biosimilars Example
Figure Global Biologics and Biosimilars Revenue (Million $) Status and Outlook (2015-2030)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Region (2015-2030)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Type (2015-2030)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Application (2015-2030)
Figure Global Biologics and Biosimilars Revenue (Million $) Comparison by Sales Channel (2015-2030)
Table Global Biologics and Biosimilars Sales by Player (2018-2020)
Table Global Biologics and Biosimilars Sales Market Share by Player (2018-2020)
Figure Global Biologics and Biosimilars Sales Market Share by Player in 2020
Table Global Biologics and Biosimilars Revenue (Million $) by Player (2018-2020)
Table Global Biologics and Biosimilars Revenue Market Share by Player (2018-2020)
Figure Global Biologics and Biosimilars Revenue Market Share by Player in 2020
Table Global Biologics and Biosimilars Average Price by Player (2018-2020)
Figure Global Biologics and Biosimilars Average Price by Player in 2020
Figure Global Biologics and Biosimilars Players Competition Situation – Top 5 Players’ Revenue Market Share in 2018
Figure Global Biologics and Biosimilars Players Competition Trends – Top 5 Players’ Revenue Market Share in 2020
Figure Example of Monoclonal Antibodies
Figure Global Monoclonal Antibodies Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Interferon
Figure Global Interferon Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Erythropoietin
Figure Global Erythropoietin Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Insulin
Figure Global Insulin Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Vaccines
Figure Global Vaccines Revenue (Million $) and Growth Rate (2015-2020)
Table Global Biologics and Biosimilars Sales by Type (2015-2020)
Table Global Biologics and Biosimilars Sales Market Share by Type (2015-2020)
Figure Global Biologics and Biosimilars Sales Market Share by Type in 2020
Table Global Biologics and Biosimilars Revenue (Million $) by Type (2015-2020)
Table Global Biologics and Biosimilars Revenue Market Share by Type (2015-2020)
Figure Global Biologics and Biosimilars Revenue Market Share by Type in 2020
Table Global Biologics and Biosimilars Average Price by Type (2015-2020)
Figure Global Biologics and Biosimilars Average Price by Type in 2020
Table Leading Players of Biologics and Biosimilars by Type in 2020
Figure Example of Tumor
Figure Global Biologics and Biosimilars for Tumor Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Diabetes
Figure Global Biologics and Biosimilars for Diabetes Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Cardiovascular
Figure Global Biologics and Biosimilars for Cardiovascular Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Hemophilia
Figure Global Biologics and Biosimilars for Hemophilia Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Other
Figure Global Biologics and Biosimilars for Other Revenue (Million $) and Growth Rate (2015-2020)
Table Global Biologics and Biosimilars Sales by Application (2015-2020)
Table Global Biologics and Biosimilars Sales Market Share by Application (2015-2020)
Figure Global Biologics and Biosimilars Sales Market Share by Application in 2020
Table Leading Consumers of Biologics and Biosimilars by Application in 2020
Figure Example of Direct Channel
Figure Global Biologics and Biosimilars for Direct Channel Revenue (Million $) and Growth Rate (2015-2020)
Figure Example of Distribution Channel
Figure Global Biologics and Biosimilars for Distribution Channel Revenue (Million $) and Growth Rate (2015-2020)
Table Global Biologics and Biosimilars Revenue by Sales Channel (2015-2020)
Table Global Biologics and Biosimilars Revenue Market Share by Sales Channel (2015-2020)
Figure Global Biologics and Biosimilars Revenue Market Share by Sales Channel in 2020
Table Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2020
Table Global Biologics and Biosimilars Market Size and CAGR by Region (2015-2030)
Table Global Biologics and Biosimilars Sales by Region (2015-2020)
Table Global Biologics and Biosimilars Sales Market Share by Region (2015-2020)
Figure Global Biologics and Biosimilars Sales Market Share by Region in 2020
Table Global Biologics and Biosimilars Revenue (Million $) by Region (2015-2020)
....continued
CONTACT DETAILS
[email protected]
+44 203 500 2763
+1 62 825 80070
971 0503084105
© 2024 Created by PH the vintage.
Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation